Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensory Rehabilitation in Chemotherapy Induced Peripheral Neuropathy (CIPN)

NCT05382520 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.

NCT NCT05382520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensory Rehabilitation in Chemotherapy Induced Peripheral Neuropathy (CIPN)
Lead sponsor
Assaf-Harofeh Medical Center
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2022
Completion date
December 1, 2025
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cipn